Prediction of cardiovascular risk in the population, connected to predisposing factors and life style, through the application of theoretical models. Development of instruments of mass calculation based on predictive equations for application on clinical databases. The main objective is the determination of the best predictive model that is suitable for our community's population for clinical decision making, which optimises the therapeutic effect with a rationalisation of pharmaceutical expenditure.